These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 22747613)

  • 1. Does response of RAS blockade on serum K+ levels influence its glycemic-mitigating response when combined with hydrochlorothiazide?
    Deedwania PC; Zappe DH; Egan BM; Purkayastha D; Samuel R; Sowers JR
    J Clin Hypertens (Greenwich); 2012 Jul; 14(7):415-21. PubMed ID: 22747613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin receptor blocker/diuretic combination preserves insulin responses in obese hypertensives.
    Sowers JR; Raij L; Jialal I; Egan BM; Ofili EO; Samuel R; Zappe DH; Purkayastha D; Deedwania PC
    J Hypertens; 2010 Aug; 28(8):1761-9. PubMed ID: 20498618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tolerability and blood pressure-lowering efficacy of the combination of amlodipine plus valsartan compared with lisinopril plus hydrochlorothiazide in adult patients with stage 2 hypertension.
    Poldermans D; Glazes R; Kargiannis S; Wernsing M; Kaczor J; Chiang YT; Yen J; Gamboa R; Fomina I
    Clin Ther; 2007 Feb; 29(2):279-89. PubMed ID: 17472820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Achieving BP goals with valsartan and HCTZ alone and in combination: pooled analysis of two randomized, double-blind, placebo-controlled studies.
    Nash DT; Crikelair N; Zappe D
    Curr Med Res Opin; 2008 Sep; 24(9):2617-26. PubMed ID: 18687165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antihypertensive and metabolic effects of Angiotensin receptor blocker/diuretic combination therapy in obese, hypertensive African American and white patients.
    Ofili EO; Zappe DH; Purkayastha D; Samuel R; Sowers JR
    Am J Ther; 2013 Jan; 20(1):2-12. PubMed ID: 22248871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term safety, tolerability and efficacy of aliskiren in combination with valsartan in patients with hypertension: a 6-month interim analysis.
    Chrysant SG; Murray AV; Hoppe UC; Dattani D; Patel S; Hsu H; Zhang J
    Curr Med Res Opin; 2008 Apr; 24(4):1039-47. PubMed ID: 18307835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of valsartan compared with valsartan/hydrochlorothiazide on plasma levels of cellular adhesion molecules: the Val-MARC trial.
    Conen D; Everett BM; Glynn RJ; Ridker PM
    Heart; 2008 Mar; 94(3):e13. PubMed ID: 17923463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of force-titrated valsartan/hydrochlorothiazide versus amlodipine/hydrochlorothiazide on ambulatory blood pressure in patients with stage 2 hypertension: the EVALUATE study.
    Lacourcière Y; Wright JT; Samuel R; Zappe D; Purkayastha D; Black HR;
    Blood Press Monit; 2009 Jun; 14(3):112-20. PubMed ID: 19384192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amlodipine/valsartan/hydrochlorothiazide: fixed-dose combination in hypertension.
    Deeks ED
    Am J Cardiovasc Drugs; 2009; 9(6):411-8. PubMed ID: 19929039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
    Ruilope LM; Malacco E; Khder Y; Kandra A; Bönner G; Heintz D
    Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the effects on 24-h ambulatory blood pressure of valsartan and amlodipine, alone or in combination with a low-dose diuretic, in elderly patients with isolated systolic hypertension (Val-syst Study).
    Palatini P; Mugellini A; Spagnuolo V; Santonastaso M; Ambrosia GB; Caiazza A; Malacco E;
    Blood Press Monit; 2004 Apr; 9(2):91-7. PubMed ID: 15096906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Office and ambulatory blood pressure-lowering effects of combination valsartan/hydrochlorothiazide vs. hydrochlorothiazide-based therapy in obese, hypertensive patients.
    Raij L; Egan BM; Zappe DH; Purkayastha D; Samuel R; Sowers JR
    J Clin Hypertens (Greenwich); 2011 Oct; 13(10):731-8. PubMed ID: 21974760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Valsartan/hydrochlorothiazide: a review of its pharmacology, therapeutic efficacy and place in the management of hypertension.
    Wellington K; Faulds DM
    Drugs; 2002; 62(13):1983-2005. PubMed ID: 12215069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of combination therapy using high- or low-dose hydrochlorothiazide with valsartan or other Angiotensin-receptor blockers.
    Fuenfstueck R; Hempel RD; Ansari A; Weidinger G; Klebs S
    Adv Ther; 2005; 22(3):263-77. PubMed ID: 16236687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 24-hour ambulatory blood-pressure effects of valsartan and hydrochlorothiazide combinations compared with amlodipine in hypertensive patients at increased cardiovascular risk: a VAST sub-study.
    Ruilope LM; Heintz D; Brandão AA; Stolt P; Kandra A; Santonastaso M; Khder Y
    Blood Press Monit; 2005 Apr; 10(2):85-91. PubMed ID: 15812256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improving blood pressure control: increase the dose of diuretic or switch to a fixed-dose angiotensin receptor blocker/diuretic? the valsartan hydrochlorothiazide diuretic for initial control and titration to achieve optimal therapeutic effect (Val-DICTATE) trial.
    White WB; Calhoun DA; Samuel R; Taylor AA; Zappe DH; Purkayastha D
    J Clin Hypertens (Greenwich); 2008 Jun; 10(6):450-8. PubMed ID: 18550935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronotherapy with valsartan/hydrochlorothiazide combination in essential hypertension: improved sleep-time blood pressure control with bedtime dosing.
    Hermida RC; Ayala DE; Mojón A; Fontao MJ; Fernández JR
    Chronobiol Int; 2011 Aug; 28(7):601-10. PubMed ID: 21823969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination therapy with various combinations of aliskiren, valsartan, and hydrochlorothiazide in hypertensive patients not adequately responsive to hydrochlorothiazide alone.
    Geiger H; Barranco E; Gorostidi M; Taylor A; Zhang X; Xiang Z; Zhang J
    J Clin Hypertens (Greenwich); 2009 Jun; 11(6):324-32. PubMed ID: 19527323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative vascular and renal tubular effects of angiotensin II receptor blockers combined with a thiazide diuretic in humans.
    Coltamai L; Maillard M; Simon A; Vogt B; Burnier M
    J Hypertens; 2010 Mar; 28(3):520-6. PubMed ID: 20104189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of valsartan/hydrochlorothiazide and amlodipine on ambulatory blood pressure and plasma norepinephrine levels in high-risk hypertensive patients.
    Malacco E; Piazza S; Scandiani L; Zoppi A
    Adv Ther; 2004; 21(3):149-61. PubMed ID: 15509131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.